OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Tel Hashomer, Israel-Results of preclinical studies suggest that minocycline has potential utility as a neuroprotective agent in the management of optic nerve diseases, said Hani Levkovitch-Verbin, MD.